Effects of Exogenous Recombinant GCSF in Patients With Repeated Implantation Failure - A Randomized Single-blind Trial

Trial Profile

Effects of Exogenous Recombinant GCSF in Patients With Repeated Implantation Failure - A Randomized Single-blind Trial

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Jul 2017

At a glance

  • Drugs Filgrastim (Primary)
  • Indications Female infertility
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 Jul 2017 Planned End Date changed from 1 Mar 2016 to 1 Dec 2020.
    • 24 Jul 2017 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2020.
    • 31 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top